Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Common Equity (2022 - 2025)

Historic Common Equity for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to -$1.0 billion.

  • Prokidney's Common Equity fell 288.94% to -$1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 288.94%. This contributed to the annual value of -$995.0 million for FY2024, which is 982.8% up from last year.
  • As of Q3 2025, Prokidney's Common Equity stood at -$1.0 billion, which was down 288.94% from -$1.0 billion recorded in Q2 2025.
  • In the past 5 years, Prokidney's Common Equity ranged from a high of -$12.4 million in Q1 2022 and a low of -$1.6 billion during Q1 2023
  • Over the past 4 years, Prokidney's median Common Equity value was -$1.0 billion (recorded in 2025), while the average stood at -$959.5 million.
  • As far as peak fluctuations go, Prokidney's Common Equity tumbled by 1285686.52% in 2023, and later surged by 3156.07% in 2024.
  • Over the past 4 years, Prokidney's Common Equity (Quarter) stood at -$1.1 billion in 2022, then dropped by 0.62% to -$1.1 billion in 2023, then increased by 9.83% to -$995.0 million in 2024, then decreased by 1.31% to -$1.0 billion in 2025.
  • Its Common Equity stands at -$1.0 billion for Q3 2025, versus -$1.0 billion for Q2 2025 and -$998.6 million for Q1 2025.